News Qiagen N.V. Deutsche Boerse AG

Equities

QIA

NL0015001WM6

Market Closed - Deutsche Boerse AG Other stock markets 04:34:10 2024-05-31 am EDT			5-day change	1st Jan Change
39.24 ^EUR	-0.18%		-2.46%	-3.17%

May. 31	Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test	MT
May. 31	Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test	May. 31	MT
Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test	May. 31	MT
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	May. 30	AQ
QIAGEN and Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test for Global Research and Companion Diagnostics Applications	May. 30	CI
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine	May. 29	AQ
Qiagen N.V. Launches New Library Preparation Kit, Facilitating Multiomic Studies and Advancing Precision Medicine	May. 29	CI
QIAGEN NV : Berenberg maintains a Buy rating	May. 21	ZD
Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	May. 15	MT
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	May. 14	AQ
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	May. 14	CI
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	May. 13	PU
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test	May. 13	MT
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel	May. 13	MT
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	May. 13	AQ
Qiagen Receives FDA Clearance for Qiastat-Dx Respiratory Syndromic Testing Panel for Fast and Accurate Results	May. 13	CI
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	May. 08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	May. 08	PU
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics	May. 08	MT
Qiagen N : Annual Report 2023, including the Reports of the Managing Board and the Supervisory Board of N.V.	May. 07	PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	May. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT